Rubis Terminal Company Profile

20:13 EDT 19th June 2018 | BioPortfolio



siege Social: 33 Avenue De


Phone: 01 53 81 86 20
Fax: 01 45 72 45 46

News Articles [119 Associated News Articles listed on BioPortfolio]

[Comment] Enhanced terminal room disinfection and the need for multimodal collaboration

Strategies to counter the ongoing global threat of multidrug-resistant organisms, including Clostridium difficile, are crucial to the future of medicine.1 The direct effect of enhanced terminal room d...

Man is steadily losing his penis to terminal penile cancer – Metro

MetroMan is steadily losing his penis to terminal penile cancerMetroA young father with a baby on the way has revealed his brave battle after being diagnosed with terminal penile cancer. Dale Clarke, ...

LBC Builds Texas Terminal for MEGlobal

Belgian storage operator LBC Tank Terminals has finalized agreements with MEGlobal Americas for the design, engineering, construction and operation of a new terminal in Texas.

Death Brings Wisdom to Dying Patients

SATURDAY, Jan. 27, 2018 -- With terminal illness comes newfound, and profound, wisdom, researchers report. They uncovered this silver lining of terminal illness as people in their final months tried t...

Video Gaming Terminal Applications Available from the Pennsylvania Gaming Control Board

The Board also announced that applications for VGT terminal operators and establishments will be accepted beginning May 7, 2018.  The date for acceptance of Read more...

Global Terminal Automation Market - Forecasts from 2018 to 2023

The global terminal automation market was valued at US$4.136 billionin 2017 and is projected to expand at a CAGR of 4.91% over the forecast Read more...

The Global M2M/IoT Terminal Market - Insights from 30 Executive Interviews with Market-leading ...

The Global M2M/IoT Terminal Market is the second consecutive strategy report analysing the latest developments on the cellular router, gateway and modem market. This strategic Read more...

Enterprise and Navigator Plan US Ethylene Terminal

US oil and gas company Enterprise Products Partners and UK shipping group Navigator Holdings have formed a 50:50 joint venture to build a 1 million t/y ethylene export terminal on the US Gulf Coast.

Drugs and Medications [9 Associated Drugs and Medications listed on BioPortfolio]

Granisetron hydrochloride [Breckenridge Pharmaceutical, Inc.]


Famotidine [Ipca Laboratories Limited]

Famotidine Tablets USP

Cetirizine hydrochloride [Ipca Laboratories Limited]

Cetirizine Hydrochloride Tablets 10 mg

Levorphanol tartrate [Roxane Laboratories, Inc]


Boniva [Genentech, Inc.]

BONIVA (ibandronate sodium) INJECTION

PubMed Articles [487 Associated PubMed Articles listed on BioPortfolio]

Preventing the N-terminal processing of human interferon α-2b and its chimeric derivatives expressed in Escherichia coli.

We have previously shown that human interferon α-2b (IFN) produced in Escherichia coli (E. coli) is heterogeneous at the N-terminal, with three major species (Ahsan et al., 2014). These are: (a) the ...

C-terminal short arginine/serine repeat sequence-dependent regulation of Y14 (RBM8A) localization.

Y14 (RBM8A) is an RNA recognition motif-containing protein that forms heterodimers with MAGOH and serves as a core factor of the RNA surveillance machinery for the exon junction complex (EJC). The rol...

Design, synthesis and evaluation of N- and C-terminal protein bioconjugates as GPCR agonists.

A GPCR agonist protein, thaumatin, was site-specifically conjugated at the N- or C-terminus with a fluorophore for visualization of GPCR:agonist interactions. The N-terminus was specifically conjugate...

1,3-Dibromo-5,5-dimethylhydantoin mediated oxidative amidation of terminal alkenes in water.

A variety of terminal alkenes were converted to the corresponding amides in yields of 25 to 86% in water via treatment with 1,3-dibromo-5,5-dimethylhydantoin, followed by reaction with molecular iodin...

Spectroscopic characterization of the Co-substituted C-terminal domain of rubredoxin-2.

Pseudomonas putida rubredoxin-2 (Rxn2) is an essential member of the alkane hydroxylation pathway and transfers electrons from a reductase to the membrane-bound hydroxylase. The regioselective hydroxy...

Clinical Trials [152 Associated Clinical Trials listed on BioPortfolio]

P-wave Terminal Force in Patients With Atrial Fibrillation.

It is suggested that P-wave terminal force (Ptf), a product of the amplitude (PAM) and the duration (PT) of the terminal phase of P-wave in lead V1, shows early delay in left atrial conduc...

Evaluation of Multidisciplinary Palliative Care on Terminal Cancer Patients in Taiwan

The purpose of the study is to compare the quality of dying and death of terminal cancer patients from the perspectives of medical staff and main care giver (family). The hypothesis is tha...

The Survey About Resting Metabolic Rate and Its Related Factors in Terminal Patients

According to data from the Taiwanese government, cancer mortality has been the leading cause of death in Taiwan since 1982. The trend is increasing day by day. As the people are aging in T...

Effectiveness of the Application(APP) on Individualized Antithrombotic Therapy

Develop an exemplary anti-thrombotic therapy network data platform and a intelligent terminal application(APP), establish an new pattern used in long-time anti-thrombotic management based ...

Improvement of Accommodation With Anti-Oxidant Supplementation in Visual Display Terminal Users

The purpose of this study is to determine the antioxidant supplementation effect on accommodation among visual display terminal (VDT) users.

Companies [33 Associated Companies listed on BioPortfolio]

Rubis Terminal


Posiflex Business Machines

Posiflex has a long legacy of exceptional touch screen terminal and peripheral quality where reliability is designed from the start. With rigorous third‐party pre and post ma...

Visual Automation, Inc

Visual Automation is a software development company, started in 1994 by Duane Fahey, former Product Manager at ICOM, Inc. (now Rockwell Software). Visual Automation is dedicated to creating high quali...

Infinitely Virtual

Infinitely Virtual is a leading provider of high quality and affordable Cloud Server technology, capable of delivering services to any type of business, via terminal servers, Shar...

Alexion Pharmaceuticals Incorporated

Alexion is a global biopharmaceutical company that combines groundbreaking science with a steadfast commitment to meeting the needs of patients living with severe, life-threatening and often ultra-rar...

More Information about "Rubis Terminal" on BioPortfolio

We have published hundreds of Rubis Terminal news stories on BioPortfolio along with dozens of Rubis Terminal Clinical Trials and PubMed Articles about Rubis Terminal for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rubis Terminal Companies in our database. You can also find out about relevant Rubis Terminal Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record